BCMA is essential for the survival of long-lived bone marrow plasma cells
about
Progress in treatment of ANCA-associated vasculitisScreening of functional and positional candidate genes in families with common variable immunodeficiencyBAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphomaThe level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signatureGraft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptorHodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRILThe current status of targeting BAFF/BLyS for autoimmune diseasesThe Role of Immunotherapy in Multiple MyelomaCytokine-Defined B Cell Responses as Therapeutic Targets in Multiple SclerosisBelimumab in systemic lupus erythematosusB-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related CachexiaB-cell survival factors in autoimmune rheumatic disordersActivation of B cells by non-canonical helper signalsHeparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myelomaFactors regulating immunoglobulin production by normal and disease-associated plasma cellsNon-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple JuncturesInfection-induced changes in hematopoiesisPotent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myelomaDevelopment of Novel Immunotherapies for Multiple MyelomaUnraveling the Role of Allo-Antibodies and Transplant InjuryBAFF regulates follicular helper t cells and affects their accumulation and interferon-γ production in autoimmunity.Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and B cell responses in lupus-prone mice.Mcl-1 is essential for the survival of plasma cells.Regulatory roles of the tumor necrosis factor receptor BCMA.B cell maturation antigen deficiency exacerbates lymphoproliferation and autoimmunity in murine lupusProtective antiviral antibody responses in a mouse model of influenza virus infection require TACIDeregulation of c-Myc Confers distinct survival requirements for memory B cells, plasma cells, and their progenitorsEfficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial).Homeostatic control of B lymphocyte subsets.High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura.Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications.Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia.Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE), BAFF and its receptors.Adjuvant-specific regulation of long-term antibody responses by ZBTB20The BTB-ZF transcription factor Zbtb20 is driven by Irf4 to promote plasma cell differentiation and longevity.Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays.The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infectionsEpstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation.Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma.
P2860
Q21195258-4750038C-9FA8-401B-938F-79E7756B1101Q21263125-05F71838-338A-4032-83D5-8AE36DC7A1C5Q24646563-4AFF7FEE-5629-418A-8221-E59BC3C6A7A3Q24647037-8FC5C25E-588F-40D9-B4C4-4F22A6254A4AQ24670205-6E0DECE1-D20F-48B7-A8AE-9B8CEF159406Q24681342-7E09C3F3-7B43-4CDA-A213-2F50149D395BQ24796930-5F6496B1-48BC-40D1-9453-CF53E94A9F8EQ26771144-3553A6F8-6859-41B4-A1C0-DBFA82225E3FQ26771459-E027B892-04EA-43C4-AD1D-7C0740E0D517Q26778277-AFEA31F2-BD54-417E-99BA-2761F8B70BB6Q26784444-AFDA2635-E268-470A-BED8-0CB548F3D1DDQ26796484-9E33357E-6AF3-4B4E-AECC-1EEE57C4D278Q26866169-9F1856F9-BBE5-4AA0-BAB8-52E9AEEA0510Q27001749-4E2D3609-5C98-49E4-AE8A-0E809A5D7E0DQ27021855-548DCD7D-0613-4592-9294-286C22D47F7AQ27024640-FD879CCD-B3A4-4C3E-93E0-0CABAEEEC655Q27027365-CCB44FB7-39C2-433E-86C5-559C3D2676E7Q27700745-CD38BE5E-7400-4BC0-91B4-C8B32AAD8374Q28066890-2DF53631-E9CE-449F-A45B-B665ADE5F5C6Q28069336-A40D1B61-DEB1-4A9C-BC7D-CBC5EFD57060Q30360393-7AECB726-9A88-4D61-BC8D-EA4A07A378F5Q30411860-716890D4-C538-445F-AB3A-86D4457993E9Q30412677-A987FF8C-DB41-4681-86F2-F5295FC12D18Q30422814-EA96ABFA-639B-4E8D-AC9E-E0D1AFD43BA8Q30426692-2B3B4B54-5512-4CBD-BB1B-4A56C289CE03Q30430255-93F0D1DE-05A5-418B-948D-CF6F949B1973Q30436741-9937A304-AA5D-4A22-8F94-6E39C0121BE3Q30832522-F1A24A6E-594F-437C-A69C-08294F58DAC3Q33345827-18AC946F-73FE-4961-87D5-2E0BD7F237D9Q33373525-9D97E554-B915-4803-A86F-E48948FE5A92Q33386608-34FB84E3-0720-4E07-BA9C-1C57DFA0714BQ33429051-04E7F63F-7889-4143-A966-1E53FFDEB4A3Q33430662-4E73691C-7789-41C1-9FDE-439ED4975403Q33521234-DB6A3B83-1B24-48B7-92B3-916B12635129Q33569857-FC85A6A7-9BFE-4F40-831C-136E68D81C83Q33569863-733C76F0-C1D8-48E7-9BD5-6E2BDF5261C0Q33577408-3D6884DA-96D8-4EDA-91C0-8826A9A9044EQ33587496-53084422-42F4-43A0-8AD1-1302DCC27FF8Q33599648-C8C6DFCE-7C50-438D-9FF3-6025ABA69A83Q33621610-998584AD-30C6-4639-8472-CC52ECD7C152
P2860
BCMA is essential for the survival of long-lived bone marrow plasma cells
description
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Januar 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/01/05)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/01/05)
@nl
наукова стаття, опублікована в січні 2004
@uk
مقالة علمية (نشرت في 5-1-2004)
@ar
name
BCMA is essential for the survival of long-lived bone marrow plasma cells
@ast
BCMA is essential for the survival of long-lived bone marrow plasma cells
@en
BCMA is essential for the survival of long-lived bone marrow plasma cells
@nl
type
label
BCMA is essential for the survival of long-lived bone marrow plasma cells
@ast
BCMA is essential for the survival of long-lived bone marrow plasma cells
@en
BCMA is essential for the survival of long-lived bone marrow plasma cells
@nl
prefLabel
BCMA is essential for the survival of long-lived bone marrow plasma cells
@ast
BCMA is essential for the survival of long-lived bone marrow plasma cells
@en
BCMA is essential for the survival of long-lived bone marrow plasma cells
@nl
P2093
P2860
P921
P3181
P356
P1476
BCMA is essential for the survival of long-lived bone marrow plasma cells
@en
P2093
Brian P. O'Connor
Cory Ahonen
George T. Mantchev
Lehn K. Weaver
Ling-Li Lin
Loren D. Erickson
Randolph J. Noelle
Richard J. Bram
Vanitha S. Raman
W. James Cook
P2860
P3181
P356
10.1084/JEM.20031330
P407
P577
2004-01-05T00:00:00Z